Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Arterial Thrombosis Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profile Snapshots 32
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Source 54
List of Tables
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Region, 2017* 6
Arterial Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Arterial Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Arterial Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Arterial Thrombosis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Arterial Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Arterial Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 18
Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Arterial Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Arterial Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Arterial Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Arterial Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Arterial Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
Arterial Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
List of Figures
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Arterial Thrombosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Arterial Thrombosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Arterial Thrombosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Arterial Thrombosis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Arterial Thrombosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Arterial Thrombosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 15
Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Arterial Thrombosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Arterial Thrombosis to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 18
Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Arterial Thrombosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Arterial Thrombosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Arterial Thrombosis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Arterial Thrombosis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Arterial Thrombosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Arterial Thrombosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Arterial Thrombosis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Arterial Thrombosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Arterial Thrombosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31
GlobalData Methodology 53
